CEO Ian Bothwell Increases Beneficial Ownership in Zeo ScientifiX to 14.7% via Equity Grants

Ian T. Bothwell, the Chief Executive Officer and Chief Financial Officer of Zeo ScientifiX, Inc. (ZEOX), filed Amendment No. 3 to his Schedule 13D on May 15, 2026. This filing reports an increase in beneficial ownership following two equity grants under the Issuer's 2021 Equity Incentive Plan. Specifically, Mr. Bothwell was granted options to purchase 55,000 shares of common stock on May 8, 2025, and 175,000 restricted shares on January 14, 2026 (of which 87,500 vest on July 14, 2026). As of the filing date, Mr. Bothwell beneficially owns 1,195,094 shares of common stock, representing approximately 14.7% of the class. This total includes 187,500 shares issuable upon warrant exercises and 180,000 shares issuable upon option exercises. Notably, Mr. Bothwell also holds 50 shares of Series C Preferred Stock, which grants him an additional 25.5% of the total voting power, bringing his aggregate voting influence to approximately 40.2%. The reporting person has sole voting and dispositive power over all reported common shares.